Associated Papers
Exome Sequencing with Validations and Expression of p16/CDKN2A Shows no Association with HPV in Oral Cancers.
Shyamsundar V et al.
Asian Pacific Journal of Cancer Prevention : Apjcp, 2022
Differential mechanisms of CDKN2A (p16) alteration in oral tongue squamous cell carcinomas and correlation with patient outcome.
Lim AM et al.
International Journal of Cancer, 2014
Constitutive mitochondrial DNA copy number in peripheral blood of melanoma families with and without CDKN2A mutations.
Hyland PL et al.
Journal of Carcinogenesis & Mutagenesis, 2014
CDKN2A but not TP53 mutations nor HPV presence predict poor outcome in metastatic squamous cell carcinoma of the skin.
Küsters-Vandevelde HV et al.
International Journal of Cancer, 2010
Frequent p16-independent inactivation of p14ARF in human melanoma.
Freedberg DE et al.
Journal of the National Cancer Institute, 2008
p16 mutation spectrum in the premalignant condition Barrett's esophagus.
Paulson TG et al.
Plos One, 2008
INK4-ARF and p53 mutations in metastatic cutaneous squamous cell carcinoma: case report and archival study on the use of Ink4a-ARF and p53 mutation analysis in identification of the corresponding primary tumor.
Blokx WA et al.
The American Journal of Surgical Pathology, 2005
The CDKN2A (p16) gene and human cancer.
Foulkes WD et al.
Molecular Medicine (cambridge, Mass.), 1997
Select a paper to view details